In aggregate, the combination of MWA with Flt3L treatment not only augments the differentiation of both TTSM and TPEX cells within the TdLN but also orchestrates remodeling of the exhaustion phenotype of CD8+ T cells within the TME, ultimately leading to the inhibition of tumor growth. The gene discussed is FLT3LG; the disease is neoplasm.